Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 26Leukemia, Myeloid, Acute 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Leukemia 23Anemia, Refractory, with Excess of Blasts 20Lymphoma 19Leukemia, Lymphocytic, Chronic, B-Cell 18Hodgkin Disease 18Lymphoma, Non-Hodgkin 17Myeloproliferative Disorders 16Anemia, Aplastic 16Multiple Myeloma 15Leukemia, Myelomonocytic, Chronic 14Leukemia, Myeloid, Chronic-Phase 13Leukemia, Myeloid, Accelerated Phase 13Burkitt Lymphoma 12Primary Myelofibrosis 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Dendritic Cell Sarcoma, Interdigitating 11Blast Crisis 11Myelodysplastic-Myeloproliferative Diseases 10Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10Congenital Abnormalities 10Recurrence 9Lymphoma, Mantle-Cell 9Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myelomonocytic, Juvenile 9Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8

Interventions

fludarabine 3fludarabine phosphate 2Cyclophosphamide 2AP 1903 reagent 2thymoglobulin 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Rituximab 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Melphalan 1Erythrocyte Count 1Dexamethasone 1Clofarabine 1Bortezomib 1Blood Transfusion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thalassemia × Melphalan × Classical hematology × Clear all
NCT03609827 2021-10-04

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡